期刊文献+

Bmi-1、hTERT在乳腺癌细胞中的表达及与凋亡的关系 被引量:7

Bmi-1,hTERT expression in breast cancer cells and its relationship with apoptosis
原文传递
导出
摘要 目的研究原癌基因Bmi-1和hTERT的表达变化及其与细胞凋亡的关系,探讨它们在乳腺癌发生、发展过程中的作用。方法采用MTT法检测乳腺癌细胞的增殖抑制情况,并确定所选用的药物浓度。RT-PCR、Western Blot检测Bmi-1、hTERT的mRNA及蛋白的表达情况;TUNEL、流式细胞技术检测乳腺癌细胞的凋亡情况。结果 5-FU对乳腺癌细胞有明显抑制作用,各实验组与对照组OD值的差异有统计学意义(P<0.05)。用5-FU干预后,实验组Bmi-1和hTERT的mRNA及蛋白表达水平均降低,细胞凋亡指数增加,与对照组相比差异显著有统计学意义(P<0.05),经统计学分析两者呈正相关(P<0.05),且两者的表达与凋亡呈负相关(P<0.05)。结论 Bmi-1和hTERT的表达下调可促进乳腺癌细胞凋亡。 Objective To study the expression changes of proto-oncogene mi-1 and hTERT, and its relationship with apoptosis and to discuss their roles in the occurrence and development of breast cancer. Methods MTT was used to detect the inhibition of breast cancer cell proliferationand the drug concentrations in the experiment; RT-PCR and Western Blot were used to detect the protein and mRNA expression. TUNEL and Flow cytometry were used to detect the apoptosis situation. Results 5-FU could significantly inhibit the growth of breast cancer cell. The differences of OD value between the groups were statistically significant (P〈0.05). Under the intervention of 5-Fu, the mRNA and Western Blot expression levels of Bmi-1 and hTERT gradually decreased, and the apoptosis index increased, which exhibited great statistical significance (P〈0.05) compared with the control group. Bmi- 1 and hTERT showed a positive correlation (P 〈 0.05),and their expression had a negative correlation with the apoptosis through the statistical analysis. Conclusion The down-regulation of Bmi-1 and hTERT expression in breast cancer cells can promote the apoptosis.
出处 《中国临床解剖学杂志》 CSCD 北大核心 2014年第1期61-66,共6页 Chinese Journal of Clinical Anatomy
关键词 乳腺癌 BMI-1 HTERT 细胞凋亡 Breast cancer Bmi-1 hTERT Apoptosis
  • 相关文献

参考文献3

二级参考文献56

  • 1冯艳,宋立兵,郭宝红,廖雯婷,李满枝,刘万里,曾木圣,张玲.Bmi-1在乳腺癌组织中的表达及意义[J].癌症,2007,26(2):154-157. 被引量:67
  • 2Haupt Y, Alexander WS, Barri G, et al. Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lym- phomagenesis in E mu-myc transgenic mice[ J]. Cell, 1991,65 (5) : 755 -763.
  • 3Arias AM. Epithelial mesenchymal interactions in cancer and development [J]. Cell, 2001 , 105 ( 4 ) :425 - 431.
  • 4Jacobs JJ, Scheijen B, Voncken JW, et al. Bmi-1 collaborates with c-myc in tumorigenesis by inhibiting c-mycinduced apoptosia via INK4a/ARF[J]. Genes Dev,1999, 13(20) : 2678 -2690.
  • 5Vonlanthen S, Heighway J, Ahermatt HJ,et al. The Bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression[ J]. Br J Cancer, 2001, 84(10) : 1372 -1376.
  • 6Park IK,Qian D, Kiel M, et al. Bmi-1 is required formaintenance of adult self-renewing haematopoieticstem cells [ J ]. Nature, 2003, 423(6937) : 302 -305.
  • 7Jaeobs JJ, Kieboom K, Marino S,et al. The oncogene and Polycomb-group gene Bmi-1 regulates cell proliferation and senes-cence through the INK4A locus [ J ]. Nature, 1999, 397:164 - 168.
  • 8Goberdhan PD, Jose-Luis M, Jacqueline LJ, et al. The Bmi-1 otacogene induces telomerase activity and immortalizes human mammary epithelial cells[J]. Cancer Research, 2002,62:4736 - 4745.
  • 9Javier S, Jose MG, Cristina P, et al. Implication of polyeomb members Bmi-1, Mel-18, and Hpc-2 in the regulation of pl6INK4A, pl4ARF, hTERT, and c-Myc expression in primary breast carcinomas[ J ]. Clin Cancer Res, 2006,12 ( 23 ) : 6929 - 6936.
  • 10Song LB, Zeng MS, Liao WT, et al. Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells [ J]. Cancer Res, 2006, 66 ( 12 ) : 6225 - 6232.

共引文献88

同被引文献56

  • 1李莉,熊永炎,刘琳,陈桃香,姚兴凤,汪燕舞.非小细胞肺癌组织中hTERT、MDR1和MRPmRNA与C-myc蛋白的表达及相关性研究[J].癌症,2005,24(1):53-57. 被引量:9
  • 2Liu S, Dontu G,,Wieha MS. Mammary stem cells, self-renewal Path- ways, and eareinogenesis [J].Breast Cancer Res,2005:7(3):8-95.
  • 3Visapaa H, Swligson D, Eeva M, et al. 8q24 amplification intransitional cell carcinoma of bladder [J]. Appl Immunohistochem Mol Morpho, 1 2003, 11(1): 33-36.
  • 4Jourdan F, Sebbaghn, COmperate,et al. Tissuemieroarray technology: validation in eoloreetal carcinoma and analysisofp53, hM-LH1, and hMSH2 immunohistochemical expression [J]. Virehows Arch, 2003, 443(2): 115-121.
  • 5Dhar DK, Udagawa J, Ishihara S, et al. Expression of regenerating gene 1 in gastric adenocareinomas: Correlation with tumor differentiation status and patient survival [J].Cancer,2004,100(6): 1130-1236.
  • 6Liu S,Dontu G,Wicha MS.Mammary stem cells,self-renewal pathways,and carcinogenesis[J].Breast Caneer Res,2005,7(3):8-95.
  • 7Visapaa H,Swligson D,Eeva M,et al.8q24amplification intransitional cell carcinoma of bladder[J].Appl Immunohistochem Mol Morphol,2003,11(1):33-36.
  • 8Jourdan F,Sebbagh N,Comperat E,et al.Tissue microarray technology:validation in colorectal carcinoma and analysis of p53,hMLH1,and hMSH2immunohistochemical expression[J].Virchows Arch,2003,443(2):115-121.
  • 9Weidner N,Semple JP,Welch WR,et al.Tumor angiogencsis and metatasis-correlation in invasive breast carcinoma[J].N Engl J Med,1991,324(1):1-8.
  • 10Dhar DK,Udagawa J,Ishihara S,et al.Expression of regenerating gene 1in gastric adenocareinomas:correlation with tumor differentiation status and patient survival[J].Cancer,2004,100(6):1130-1136.

引证文献7

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部